Novocure Sees Promising Results in Brain Cancer Trial

Solid tumor treatment company Novocure said a pivotal Phase III trial showed that its NovoTTF therapy for recurrent glioblastoma multiforme brain tumors was comparable to active chemotherapy in extending overall survival, with minimal side effects and far better quality of life.
Mass High Tech